Bone mass—the total amount of mineralized tissue in your skeleton—is not a tool you hold, but a vital metric you can actively manage. Understanding how to “use” bone mass means knowing when and how to measure it, how to interpret the numbers, and how to apply that data to daily habits that preserve or improve skeletal strength. This guide walks you through the entire process, from preparing for a DEXA scan to adjusting your lifestyle based on results.
Before you can use bone mass data, you need a reliable starting point. The gold standard is a Dual-Energy X-ray Absorptiometry (DEXA) scan, which measures bone mineral density (BMD) at the hip and spine. Follow these steps for an accurate baseline:
Schedule appropriately: Avoid scheduling a DEXA scan within 72 hours of any nuclear medicine test (e.g., a bone scan) or a barium contrast X-ray, as residual contrast can artificially inflate readings.
Wear minimal metal: Remove belts, zippers, and underwire bras. Metal artifacts cause false high or low readings, depending on location.
Disclose medications: Inform the technician if you take calcium supplements within 24 hours of the scan—this rarely affects DEXA, but some clinics prefer you skip them. More importantly, list any bisphosphonates, steroids, or hormone therapy you use, as these alter your baseline trajectory.
Stay still and breathe normally: During the 10–15 minute scan, remain completely motionless. Even small shifts can blur the region of interest, forcing a repeat.Result format: You will receive a T-score (compared to a healthy 30-year-old adult) and a Z-score (compared to people your age, sex, and ethnicity). For clinical use, the T-score is primary:
T-score ≥ -1.0: Normal bone mass
T-score between -1.0 and -2.5: Osteopenia (low bone mass)
T-score ≤ -2.5: OsteoporosisActionable tip: If this is your first scan, ask for a printed copy of the BMD values in grams per square centimeter (g/cm²), not just the T-score. This raw number is your true baseline for future comparisons.
Bone mass is not static; it responds to aging, hormones, nutrition, and exercise. Using it correctly means tracking changes over time—but not too often.
For healthy adults under 50: No routine monitoring is needed unless you have risk factors (e.g., eating disorders, chronic steroid use, early menopause). If you do, a repeat scan every 2–3 years is reasonable.
For those with osteopenia: Repeat DEXA every 1–2 years. If you start a new medication or resistance training program, wait at least 12 months before the follow-up scan—bone remodeling cycles take 6–9 months, so earlier scans will not show meaningful change.
For those with osteoporosis on treatment: Repeat every 1–2 years to assess drug efficacy. If you are on a “drug holiday” (a planned break from bisphosphonates), scan every 2 years minimum.Critical error to avoid: Never compare DEXA results from different machines or different clinics unless both are cross-calibrated. A 0.02 g/cm² difference can be machine noise, not real bone loss. Always request that the follow-up scan be performed on the same scanner model, ideally the same unit.
Raw bone mass readings are meaningless without context. Use these three filters:
1. Peak bone mass comparison: Your T-score is relative to a 30-year-old’s average. If you are 60, a T-score of -1.5 means you have lost about 15% of your youthful peak—but that may be normal for your age. Focus on the Z-score: if your Z-score is below -2, you have more bone loss than expected for your age, prompting a search for secondary causes (thyroid disease, vitamin D deficiency, celiac disease, multiple myeloma).
2. Rate of change: Calculate the annual percentage change:
`[(Current BMD - Previous BMD) / Previous BMD] × 100 / years between scans`.
A loss of >3% per year at the hip is considered rapid and warrants aggressive intervention. A gain of 1–2% per year on anabolic therapy (e.g., teriparatide) is an excellent response.
3. Fracture risk integration: Bone mass alone does not predict fractures. Use a tool like FRAX (Fracture Risk Assessment Tool) that combines your T-score with age, sex, BMI, smoking, alcohol, prior fracture, and parental hip fracture. A 10-year major osteoporotic fracture risk of ≥20% or hip fracture risk ≥3% means you should consider pharmacotherapy even if your T-score is only -2.0.
Once you know your bone mass status, use it to drive specific behaviors:
If you have normal bone mass (T-score > -1.0):
Maintain with loading exercises: Perform 30 minutes of weight-bearing activity (jogging, stair climbing, jumping rope) at least 4 days per week. Add progressive resistance training (squats, deadlifts, overhead presses) twice weekly, aiming for 8–12 repetitions at 70–80% of your one-rep max.
Ensure intake: Consume 1,000–1,200 mg of calcium daily from food (dairy, leafy greens, fortified tofu) and 600–800 IU of vitamin D3. Do not exceed 2,000 mg calcium from supplements—excess can cause kidney stones and vascular calcification.If you have osteopenia (T-score -1.0 to -2.5):
Prioritize impact and resistance: Add plyometric exercises (box jumps, lateral hops) if your joints allow. Use free weights or resistance bands for hip and spine loading—machines that support your body weight (leg press) do not stimulate bone as effectively as free-standing exercises.
Correct deficiencies: Check serum 25-hydroxyvitamin D. If below 30 ng/mL, supplement with 1,000–2,000 IU daily until levels normalize. Recheck after 3 months.
Reduce bone stealers: Limit alcohol to ≤2 drinks/day and quit smoking. Both directly impair osteoblast function.If you have osteoporosis (T-score ≤ -2.5):
Safety-first exercise: Avoid spinal flexion (forward bending, sit-ups, toe touches) and high-impact jumping. Instead, do aquatic exercises, recumbent cycling, and isometric core work. Use a backpack or weighted vest (1–2 kg) during walking to gently load the spine.
Medication adherence: If prescribed bisphosphonates (alendronate, risedronate), take them on an empty stomach with plain water, remain upright for 30–60 minutes, and do not lie down. For denosumab (Prolia), you must receive the injection every 6 months without gaps—missing a dose causes rapid rebound bone loss.
Fall-proof your environment: Use your bone mass data as motivation to remove throw rugs, install grab bars, and improve lighting. A fracture at this stage is far more dangerous than the low bone mass itself.Bone mass scans are infrequent. In between, use surrogate markers to gauge whether your interventions are working:
Height measurement: Measure your standing height at the same time of day (morning is tallest) annually. A loss of >2 cm (0.8 inches) suggests vertebral compression fractures, even if you feel no pain.
Urinary calcium (24-hour test): If you are supplementing calcium, a urine calcium >300 mg/day indicates you are absorbing it but excreting it—consider splitting doses (500 mg twice daily) to improve retention.
Bone turnover markers: Blood tests for P1NP (formation) and NTX (resorption) can be measured 3–6 months after starting therapy. A drop in NTX of >30% within 3 months of bisphosphonate use indicates good adherence and effect. These tests are not routine but are useful if you doubt your response.
Do not over-supplement calcium without vitamin K2: Vitamin K2 (menaquinone-7, 100–200 mcg/day) helps direct calcium into bone rather than arteries. If your diet is low in natto, cheese, or egg yolks, consider a K2 supplement.
Do not rely on heel ultrasound or peripheral QCT for monitoring: These devices are useful for screening but have poor precision for tracking small changes. Always follow up with DEXA.
Do not ignore glucocorticoid use: Even 5 mg/day of prednisone for 3 months can cause significant bone loss. If you take steroids, discuss starting a bisphosphonate immediately, regardless of your baseline T-score.
Do not stop weight-bearing exercise after a scan shows improvement: Bone mass gains are reversible. Detraining for 12 months can erase
